Scholars Central

Conference abstractPublished 26 Jun 2017

Hyaluronan reverses Imatinib dependent-senescence in chronic myeloid leukemia cell lines

Authors: Lompardia Silvina Laura, Díaz Mariángeles, Pibuel Matías, Papademetrio Daniela Laura, Mihalez Cintia Yamila, Levermann Martín, Álvarez Elida, Hajos Silvia Elvira

University of Buenos Aires, Argentina

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Chronic myeloid leukemia (CML) is a myeloproliferative syndrome characterized by the presence of the Philadelphia chromosome which encodes a constitutively activated tyrosine kinase (BCR-ABL). The first line treatment for CML consists on BCR-ABL inhibitors such as Imatinib. Nevertheless, such treatment may lead to the selection of resistant cells. Hyaluronan (HA) is the main glycosaminoglycan of the extracellular matrix which is involved in tumor progression and multidrug resistance. We have previously demonstrated that HA induce cell proliferation in CML cells. However, the effect of HA on Imatinib therapy remains unknown. The aim of this work was to determine whether HA is able to reverse the anti-proliferative, pro-apoptotic and pro-senescent effect of Imatinib in human CML cell lines. For this purpose, K562 (ATCC) and Kv562 (multidrug resistant derived) were exposed to HA, Imatinib or a combination of both. Cell proliferation was evaluated by 3H-T uptake; apoptosis was determined by annexin-VPE- 7AAD kit, SubG1 peak and DNA fragmentation; senescence was evaluated by senescence-associated Ã?²-galactosidase activity (SA-Ã?²-gal) and senescence-associated heterochromatin foci (SAHF) presence. We showed that HA reversed the anti-proliferative effect of Imatinib without modifying Imatinib-dependent apoptosis in both cell lines. However, the combination of HA and Imatinib decreased SA-Ã?²-gal activity and SAHF presence when compared to Imatinib alone. Moreover, Imatinib treatment decreased pAkt/ Akt ratio in both cell lines and reduced the pERK/ERK ratio only in K562 cells, while the addition of HA reversed such effects. We conclude that HA reverses de anti-proliferative and pro-senescent effect of Imatinib without modifying apoptosis.

Subjects

Haematology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Glycobiology.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Glycobiology
  • SubjectHaematology
  • BylineArticles whose byline prints “Lompardia Silvina Laura”
  • BylineArticles whose byline prints “Díaz Mariángeles”
  • BylineArticles whose byline prints “Pibuel Matías”
  • BylineArticles whose byline prints “Papademetrio Daniela Laura”
  • BylineArticles whose byline prints “Mihalez Cintia Yamila”
  • BylineArticles whose byline prints “Levermann Martín”
  • BylineArticles whose byline prints “Álvarez Elida”
  • BylineArticles whose byline prints “Hajos Silvia Elvira”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels